Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke
Comparison in people · 2006
- What was studied
- Two comparative series: 35 patients in a Cortexin–Nootropil comparison and 45 in a Cortexin–Cerebrolysin comparison
- Main finding
- Authors described broadly similar clinical effects in moderate ischemic stroke and some practical advantages for Cortexin.
Reported findings and study design
Two comparative series: Cortexin versus Nootropil in 35 patients; Cortexin versus Cerebrolysin in 45 patients.
Population or model Two comparative series: 35 patients in a Cortexin–Nootropil comparison and 45 in a Cortexin–Cerebrolysin comparison
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Moderate-stroke clinical effects | Described as similar across the compared preparations | Arm sizes, effect estimates and noninferiority margins absent |
The two series and three preparations should not be treated as a single randomized ranking.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Allocation, masking and usable between-group effect estimates are unclear.
- This is not a reliable head-to-head ranking or proof of equivalence.
Source details
Indexed citation and abstract reviewed via Europe PMC / PubMed; full methods and risk of bias not comprehensively appraised.
Abstract reviewed
Sources checked
Citation
Skorokhodov AP, Dudina AA, Kolesnikova EA, Koron AE, Kobantsev IuA, Sedova AA. Comparative analysis of efficacy of certain neuroprotectors in ischemic stroke Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · PMID 18193579
Related compounds
Cortexin
A polypeptide extract of animal cerebral cortex. Its active material is a mixture of low-molecular-weight peptides studied in neurological rehabilitation, stroke and pediatric neurology.
Piracetam
A synthetic compound in the racetam family, also known by the brand Nootropil. It appears in neurological research and historical fatigue-related combination studies.
Cerebrolysin
An injectable hydrolysate of porcine brain tissue containing small peptides and free amino acids. Clinical studies have examined recovery after stroke and cognition in Alzheimer’s disease.